Primary treatment of advanced ocular surface and adnexal squamous cell carcinoma with intravenous cemiplimab.
Publication
, Journal Article
Robbins, JO; Houser, KH; Dermarkarian, CR
Published in: Orbit
December 18, 2024
Duke Scholars
Published In
Orbit
DOI
EISSN
1744-5108
Publication Date
December 18, 2024
Start / End Page
1
Location
England
Related Subject Headings
- Ophthalmology & Optometry
- 3212 Ophthalmology and optometry
- 3203 Dentistry
- 1103 Clinical Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Robbins, J. O., Houser, K. H., & Dermarkarian, C. R. (2024). Primary treatment of advanced ocular surface and adnexal squamous cell carcinoma with intravenous cemiplimab. Orbit, 1. https://doi.org/10.1080/01676830.2024.2439333
Robbins, James O., Kourtney H. Houser, and Christopher R. Dermarkarian. “Primary treatment of advanced ocular surface and adnexal squamous cell carcinoma with intravenous cemiplimab.” Orbit, December 18, 2024, 1. https://doi.org/10.1080/01676830.2024.2439333.
Robbins JO, Houser KH, Dermarkarian CR. Primary treatment of advanced ocular surface and adnexal squamous cell carcinoma with intravenous cemiplimab. Orbit. 2024 Dec 18;1.
Robbins, James O., et al. “Primary treatment of advanced ocular surface and adnexal squamous cell carcinoma with intravenous cemiplimab.” Orbit, Dec. 2024, p. 1. Pubmed, doi:10.1080/01676830.2024.2439333.
Robbins JO, Houser KH, Dermarkarian CR. Primary treatment of advanced ocular surface and adnexal squamous cell carcinoma with intravenous cemiplimab. Orbit. 2024 Dec 18;1.
Published In
Orbit
DOI
EISSN
1744-5108
Publication Date
December 18, 2024
Start / End Page
1
Location
England
Related Subject Headings
- Ophthalmology & Optometry
- 3212 Ophthalmology and optometry
- 3203 Dentistry
- 1103 Clinical Sciences